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BSTRACT
Background:
 
Because microflora has been reported
to have an important effect on the development of
allergic disorders, we measured intestinal microflora
levels in 4-month-old infants and studied the develop-
ment of allergic disorders.
 
Methods:
 
Blood samples from 18 4-month-old infants
and 15 1-year-old infants were examined for total
serum IgE and specific IgE antibodies. Stool samples
from 18 4-month-old infants were examined for the
presence of microflora.
 
Results:
 
A positive correlation was observed between
the ratio of breast-feeding at 1 month and the percent-
age of bifidobacteria in the intestine at 4 months
(correlation ratio = 0.54; 
 
P
 
 = 0.022). Atopic derma-
titis was observed in 12 of 18 infants at 4 months and
in five of 15 infants at 1 year. Egg white-specific IgE
was positive (
 
≥
 
 0.70 U
 
A
 
/mL) in six infants at 4 months
and in seven infants at 1 year. No relationship was
observed between the percentage of bifidobacteria,
lactobacilli or clostridia in the intestinal tract at
4 months and the development of allergy. However,
all five infants who exhibited a percentage of bacter-
oides (compared with the total intestinal microflora
level) of more than 10% at 4 months had positive egg
white-specific IgE and higher levels of total IgE
(>25 IU/mL) at 1 year; these relationships were statis-
tically significant (
 
P =
 
 0.01).
 
Conclusions:
 
Colonization with bacteroides at 4
months of age is suggested to be related to the allergic
state at 1 year of age.
 
Key words:
 
allergy, bacteroides, bifidobacteria, egg
white-specific IgE, intestinal microflora.
 
I
 
NTRODUCTION
 
The intestinal mucosa, which is exposed to various
allergens, including foods, is important for host defense.
The intestinal microflora has been reported to have a
significant effect on the development of allergic dis-
orders.
 
1,2
 
 Furthermore, oral tolerance has been reported
to be inducible in germ-free mice by the reconstitution of
intestinal flora with 
 
Bifidobacterium infantis.
 
3
 
 In humans,
oral intake of 
 
Lactobacillus
 
 GG has been reported
to prevent the development of allergic disorders
 
4
 
 and
 
Lactobacillus
 
 strains have proven effective in food
allergy
 
5
 
 and in atopic dermatitis.
 
6
 
In reports from various countries, different kinds of
bacteria, including clostridia and bifidobacteria, have
been reported to affect the development of allergy.
 
1,2
 
 We
studied such relationships in Japan, ascertaining whether
there may be any difference in intestinal microflora levels
with different life styles. We measured the intestinal
microflora levels at 4 months of age to investigate the
relationship with the existence of atopic dermatitis at
4 months of age and with the development of allergy
at 1 year of age.
 
M
 
ETHODS
 
Informed consent for participation in the present study,
which was approved by the ethics committee of our
hospital, was obtained from the parents of 20 1-month-
old infants, all of whom had a family history of allergy
(Table 1). We asked the mothers about the approximate
ratio of breast and formula feeding, and asked them to
visit our hospital with their infants at 4 months of age
because atopic dermatitis frequently develops at that
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age. At that time, medical check-ups, including assess-
ments for the presence of atopic dermatitis and a blood
sample examination, were undertaken. We also took
stool samples from 18 infants, but could not take a
sufficient amount of stool sample from two infants. At
1 year of age, medical check-ups and a blood sample
examination were again administered to 15 of the 18
infants. Blood samples at 4 months and 1 year of age
were examined for total serum IgE and specific IgE
antibodies for house dust, 
 
Dermatophagoides pteronis-
sinus
 
, egg white, cow’s milk, wheat, soy bean and rice.
The presence of microflora in stool samples was
analyzed based on previously described methods
 
7
 
(supported financially by Nikken Chemicals, Tokyo,
Japan). Briefly, approximately 1 g stool samples was
mixed well and suspended in 9 mL recommended dilu-
ent. The suspension was serially diluted 10-fold with the
same diluent to a 10
 
–8
 
 dilution. These procedures were
performed in an anaerobic chamber. The diluted suspen-
sions (50 
 
µ
 
L aliquots) were each streaked onto 15 dif-
ferent agar media and incubated in the respective
conditions required for optimal growth of each organ-
ism.
 
7
 
 The colonies grown on these agar plates were then
used for bacterial identification and cell numbers
counted.
Statistical significance was examined using StatMate III
(ATMS, Tokyo, Japan).
 
R
 
ESULTS
 
Development of allergy
 
Atopic dermatitis was observed in 12 infants at 4 months
of age and in five infants at 1 year of age (Table 1). The
egg white-IgE titer was positive (
 
≥
 
 0.70 U
 
A
 
/mL) in six
infants at 4 months and in seven infants at 1 year of age
(Table 1). Specific IgE titer for cow’s milk, wheat, soy
bean or rice was negative in all infants at 4 months and
1 year of age. Case 11 had experienced wheezing and
another subject (case 17) was diagnosed as having
bronchial asthma. 
 
Dermatophagoides pteronissinus
 
-
specific IgE was positive in only one infant (case 2;
2.1 U
 
A
 
/mL at 1 year of age). No relationship was
observed between the ratio of breast-feeding and the
development of allergic manifestations (Table 1).
 
Intestinal microflora at 4 months of age
 
A positive correlation was observed between the ratio
of breast-feeding at 1 month and the percentage of
bifidobacteria (compared with the total intestinal micro-
flora level) at 4 months of age (correlation ratio = 0.54;
 
P
 
 = 0.022; Fig. 1). Such a correlation was not observed
between the percentage of bifidobacteria in the intestinal
tract and the ratio of breast-feeding at 4 months of age
(Table 1). No relationship was observed between the
ratio of breast-feeding and any other intestinal micro-
flora (Table 1). None of the 10 infants who exhibited a
percentage of bifidobacteria greater than 70% and
seven of eight infants with bifidobacteria of less than
70% showed a percentage of bacteroides of more
than 10% (Table 1).
 
Relationship between microflora at 4 months 
of age and allergic manifestations
 
No relationship was observed between the percentage
of bifidobacteria, lactobacilli or clostridia in the intestinal
tract at 4 months of age and the development of atopic
dermatitis or the level of serum egg white-IgE at
4 months or 1 year of age (Table 1; Fig. 2). However,
all five infants who exhibited a percentage of bac-
teroides greater than 10% at 4 months of age had a
positive egg white-IgE titer at 1 year of age (Fig. 3) and
had a total IgE level of more than 25 IU/mL at 1 year of
age (Table 1); these results were statistically significant
according to Fisher’s exact test (
 
P =
 
 0.01).
Three infants had wheezing/bronchial asthma or a
house dust mite allergy, but there were no significant
characteristics of intestinal microflora in these three
cases.
 
Fig. 1
 
Relationship between the ratio of breast-feeding at
1 month of age and the percentage of bifidobacteria in the
intestine at 4 months of age.
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Administration of ketotifen and elimination 
diets
 
Ketotifen had been administered for more than 1 month
in five infants to control atopic dermatitis. Four of these
five infants given ketotifen and three of the 13 infants not
given ketotifen exhibited more than 10% bacteroides in
their intestinal microflora at 4 months of age; however,
this was not statistically significant (
 
P =
 
 0.055).
Elimination diets for specific foods suspected as aller-
gens were continued until 1 year of age in five infants:
elimination of egg for all five infants and milk for one
infant (case 1). Three of five infants with elimination diets
and four of 13 infants without elimination diets exhibited
more than 10% bacteroides in their intestinal microflora
at 4 months of age; however, this was not statistically
significant.
Six infants were given ketotifen and/or elimination
diets. Five of the six infants had positive egg white-IgE
and higher levels of total IgE at 1 year of age.
 
D
 
ISCUSSION
 
In the present study, 4-month-old infants in whom
bacteroides accounted for more than 10% of the intesti-
nal microflora showed a higher prevalence of positive
egg white-IgE and a higher level of total IgE at 1 year
of age, suggesting that colonization of bacteroides
at 4 months of age was related to an allergic state at
1 year of age. A percentage of bacteroides greater than
10% of the intestinal microflora at 4 month of age may
be a predictive factor for allergy at 1 year of age.
The correlation between serum total IgE levels and
bacteroides counts has been reported.
 
8
 
 Feces of infants
who were later diagnosed as cow’s milk allergy have
been reported to have a tendency to contain higher
numbers of bacteroides than healthy infants.
 
9
 
 In the
present study, we suggested a positive correlation of
bacteroides to allergy and possible mechanisms to
explain such correlations can be speculated. In the
present study, none of the infants who had a percentage
of bacteroides greater than 10% showed a percentage of
bifidobacteria greater than 70%. Bifidobacterial supple-
mentation protects against an increase in bacteroides
numbers in intestinal microflora.
 
8
 
 Bifidobacteria seem to
modify the intestinal microflora in a manner that may
alleviate allergic inflammation.
 
3,8,10
 
 
 
In vitro
 
 experiments
have shown that Gram-positive bacteria, including 
 
Bifido-
bacterium adolescentis and Lactobacillus plantarum
 
,
induce considerably higher levels of interleukin-12,
which can induce a Th1 response, than Gram-negative
bacteria, including 
 
Bacteroides vulgatus
 
, in mononuclear
cells.
 
11
 
 Therefore, the percentage of bifidobacteria
decreased in accordance with an increased percentage
of bacteroides, which may indicate a potential mecha-
nism of bacteroides for atopic sensitization, although
 
Fig. 2
 
Relationship between the percentage of bifidobacteria
in the intestine at 4 months of age and the presence of egg
white-IgE at (a) 4 months and (b) 1 year of age.
 
Fig. 3
 
Relationship between the percentage of bacteroides in
the intestine at 4 months of age and the presence of egg white-
IgE at (a) 4 months and (b) 1 year of age.
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there was no relationship between the percentage of
bifidobacteria and allergy in the present study. Another
possible mechanism may be the direct effect of bac-
teroides on the intestinal mucosa. 
 
Bacteroides fragilis
 
enterotoxin has been reported to have proteolytic activity
that may cause intestinal damage.
 
12
 
 Further investigation
will be necessary to ascertain how bacteroides may affect
allergic inflammation.
Bifidobacteria have been reported to become domi-
nant in breast-fed infants.
 
13–15
 
 In the present study,
breast-fed infants had more bifidobacteria in their intes-
tines, but intestinal bifidobacteria had no significant
effect on allergic manifestations. Because breast-feeding
may have an effect on the development of allergy,
although its influence appears contradictory,
 
16–18
 
 further
investigation using infants fed formula only will be neces-
sary to investigate the effect of intestinal microflora levels,
including bifidobacteria and bacteroides, on allergic
manifestations.
The results of the present study suggest that bac-
teroides have a positive effect on allergic sensitization. It
has been reported that counts of bacteroides at 3 months
of age did not differ between allergic and non-allergic
children, and were even lower at 12 months of age in
allergic children than in non-allergic children, in Estonia
and Sweden.
 
2
 
 However, the counts of clostridia have
been reported to be higher in allergic children than in
non-allergic in Finland, Estonia and Sweden.
 
1,2
 
 In the
present study, no significant relationship was observed
between the percentage of clostridia (compared with the
total intestinal microflora level) and allergic manifesta-
tions. The differences between our results and those of
others regarding the relationship between intestinal
microflora and the development of allergic manifesta-
tions may be caused by differences in the timing of stool
collection and in the standards of living, including envi-
ronment and diet.
Six infants were given ketotifen and/or elimination
diets. Although ketotifen and elimination diets are
thought to be effective in the treatment of allergy, five of
the six infants had positive egg white-IgE and higher
levels of total IgE at 1 year of age. However, one of these
infants (case 2) showed a total IgE level of less than
25 IU/mL and a negative egg white-IgE at 1 year of age;
this infant had a percentage of bacteroides of less than
10% at 4 months. It is unclear whether the decreased
level of IgE found in this infant at 1 year of age was due to
treatment with ketotifen and the elimination diet, or the
small percentage of bacteroides at 4 months of age, or
both. Further investigation with more subjects will be
needed to clarify the relevance of several factors, includ-
ing not only these treatments, but also genetic back-
grounds and familial life styles, to the clinical course
of allergy in relation to the development of intestinal
microflora.
 
R
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